.@stanfordmed CRISPR clinical trials will address a range of sickle-cell and metabolic, autoimmune, and neurogenerative diseases. http://stanford.io/2B2F3vI pic.twitter.com/jMLyH3usoL
7:15 PM - 19 Dec 2017
0 replies
28 retweets
73 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.